Table 1.
Characteristics of the patients with psoriatic arthritis and rheumatoid arthritis.
| Patients | n (%) 268 (100%) |
|---|---|
| Sex | |
| Female | 196 (73.1) |
| Male | 72 (26.9) |
| Age | |
| 19–59 | 156 (58.2) |
| 60 or more | 112 (41.8) |
| mean ± sd | 55.8 ± 13 |
| Diagnostic | |
| Psoriatic arthritis only | 63 (23.6) |
| Rheumatoid arthritis only | 196 (73.1) |
| RA+PsA | 9 (3.3) |
| Comorbidity* | |
| None | 130 (48.5) |
| 1 or more | 138 (51.5) |
| Psoriasis | 52 (37.7) |
| Cardiovascular | 61(44.2) |
| Metabolic | 34 (24.6) |
| Skeletal muscle | 35 (25.4) |
| Others | 28 (20.3) |
| Duration use of biologic agents (months) | |
| 6 – 12 | 40 (14.9) |
| 13 – 36 | 133 (49.6) |
| 37 or more | 95 (35.4) |
| mean ± sd | 35.7 ± 20 |
| Health care | |
| Private | 56 (20.9) |
| Public | 212 (79.1) |
| Concomitant use of drugs with biologic agent | |
| None | 81 (30.2) |
| 1 | 73 (27.2) |
| 2 or more | 114 (42.6) |
| DMARD used with biologic agent | |
| metrotexate | 57 (21.3) |
| corticosteroids | 24 (8.9) |
| Others | 64 (23.9) |
| Time since diagnostic of disease RA/PSAR | |
| <1 years | 5 (1.9) |
| 1–3 years | 9 (3.3) |
| 3–5 years | 31 (11.6) |
| >6 years | 223 (83.2) |
*Patients may have more than one comorbidity.
PsA, Psoriatic arthritis; RA, rheumatoid arthritis.